Literature DB >> 30276532

Skin microvascular dysfunction as an early cardiovascular marker in primary hyperoxaluria type I.

Alexandra Bruel1,2, Justine Bacchetta1,3, Tiphanie Ginhoux4, Christelle Rodier-Bonifas5, Anne-Laure Sellier-Leclerc1, Bérengère Fromy6, Pierre Cochat1,3,6, Dominique Sigaudo-Roussel6, Laurence Dubourg7,8,9,10.   

Abstract

BACKGROUND: Primary hyperoxaluria type 1 (PH1) is an orphan inborn error of oxalate metabolism leading to hyperoxaluria, progressive renal failure, oxalate deposition, and increased cardiovascular complications. As endothelial dysfunction and arterial stiffness are early markers of cardiovascular risk, we investigated early endothelial and vascular dysfunction in young PH1 patients either under conservative treatment (PH1-Cons) or after combined kidney liver transplantation (PH1-T) in comparison to healthy controls (Cont-H) and patients with a past of renal transplantation (Cont-T).
METHODS: Skin microvascular function was non-invasively assessed by laser Doppler flowmetry before and after stimulation by current, thermal, or pharmacological (nitroprussiate (SNP) or acetylcholine (Ach)) stimuli in young PH1 patients and controls.
RESULTS: Seven PH1-Cons (6 F, median age 18.2) and 6 PH1-T (2 F, median age 13.3) were compared to 96 Cont-H (51 F, median age 14.2) and 6 Cont-T (4 F, median age 14.5). The endothelium-independent vasodilatation (SNP) was severely decreased in PH1-T compared to Cont-H. Ach, current-induced vasodilatation (CIV), and thermal response was increased in PH1-Cons and Cont-T compared to controls.
CONCLUSIONS: PH1-T patients displayed severely decreased smooth muscle capacity to vasodilate. An exacerbated endothelial-dependent vasodilation suggests a role for silent inflammation in the early dysfunction of microcirculation observed in PH1-Cons and Cont-T.

Entities:  

Keywords:  Cardiovascular risk; Endothelium; Hyperoxaluria type I; Microcirculation; Renal transplantation

Year:  2018        PMID: 30276532     DOI: 10.1007/s00467-018-4081-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  44 in total

1.  Endothelial function: a barometer for cardiovascular risk?

Authors:  Joseph A Vita; John F Keaney
Journal:  Circulation       Date:  2002-08-06       Impact factor: 29.690

2.  Validation of laser Doppler flowmetry coupled with intra-dermal injection for investigating effects of vasoactive agents on the skin microcirculation in man.

Authors:  Stephen J Leslie; Jonathan Affolter; Martin A Denvir; David J Webb
Journal:  Eur J Clin Pharmacol       Date:  2003-04-30       Impact factor: 2.953

3.  Low skin temperature impairs the cutaneous vasodilator response to local progressive pressure strain.

Authors:  Audrey Koïtka; Marie Sophie Legrand-Fernandez; Pierre Abraham; Lionel Fizanne; Bérengère Fromy; Dominique Sigaudo-Roussel; Jean Louis Saumet
Journal:  Microvasc Res       Date:  2004-03       Impact factor: 3.514

Review 4.  Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus.

Authors:  Bernard I Levy; Ernesto L Schiffrin; Jean-Jacques Mourad; Denis Agostini; Eric Vicaut; Michel E Safar; Harry A J Struijker-Boudier
Journal:  Circulation       Date:  2008-08-26       Impact factor: 29.690

Review 5.  Non-invasive vascular function tests: their pathophysiological background and clinical application.

Authors:  Hirofumi Tomiyama; Akira Yamashina
Journal:  Circ J       Date:  2009-11-17       Impact factor: 2.993

6.  Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy.

Authors:  Jérôme Harambat; Karlijn J van Stralen; Laura Espinosa; Jaap W Groothoff; Sally-Anne Hulton; Rimante Cerkauskiene; Franz Schaefer; Enrico Verrina; Kitty J Jager; Pierre Cochat
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

7.  Impact of aortic stiffness on survival in end-stage renal disease.

Authors:  J Blacher; A P Guerin; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

8.  Anemia in patient with primary hyperoxaluria and bone marrow involvement by oxalate crystals.

Authors:  Vitaliy Mykytiv; Fiz Campoy Garcia
Journal:  Hematol Oncol Stem Cell Ther       Date:  2017-10-16

9.  Impaired pressure-induced vasodilation at the foot in young adults with type 1 diabetes.

Authors:  Audrey Koïtka; Pierre Abraham; Beatrice Bouhanick; Dominique Sigaudo-Roussel; Claire Demiot; Jean Louis Saumet
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

10.  Primary hyperoxaluria.

Authors:  Jérôme Harambat; Sonia Fargue; Justine Bacchetta; Cécile Acquaviva; Pierre Cochat
Journal:  Int J Nephrol       Date:  2011-06-16
View more
  1 in total

1.  ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.

Authors:  Gema Ariceta; Laure Collard; Saoussen Abroug; Shabbir H Moochhala; Edward Gould; Abir Boussetta; Mohamed Ben Hmida; Sudarsana De; Tracy E Hunley; Faical Jarraya; Gloria Fraga; Ana Banos; Elisabeth Lindner; Bastian Dehmel; Gesa Schalk
Journal:  Pediatr Nephrol       Date:  2022-05-12       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.